Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Larvae 'could replace use of adult fish in pain research'
zebrafish
The team recommend that larval zebrafish could be used as a model for the study of pain.

Scientists find larval zebrafish respond to pain and pain relief

Liverpool researchers say larval zebrafish could be used as an alternative model for the study of pain, sparing the many adult zebrafish that are currently used in toxicity tests.

The University of Liverpool's Dr Lynne Sneddon, who debunked the theory that fish cannot feel pain, was uncomfortable about the increasing use of adult fish in pain research, and decided to lead a study on replacing them with larvae that are just a matter of days old.

Researchers exposed five-day post-fertilisation zebrafish embryos to dilute concentrations of acetic acid and citric acid, which are known to irritate adult fish.

Using software to track their motions, the team found that in the most concentrated solutions of acetic acid, and all concentrations of citric acid, the minute fish swam harder and farther, possibly to escape the uncomfortable feeling. However, the larvae became less active in the two most dilute solutions of acetic acid.

When researchers administered pain relief to the disturbed larvae (in the form of aspirin, morphine and lidocaine) the discomfort appeared to ease and their behaviour returned to normal.

As a result the team recommend that larval zebrafish could be used as a model for the study of pain. Their full findings were published in the Journal of Experimental Biology

Image by Oregon State University (CC BY-SA 2.0)

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.